BCL2 and B-cell non-Hodgkin lymphoma: High-grade B-cell lymphoma with MYC and BCL2 rearrangements comprised 9% of all large B-cell lymphoma specimens in our cohort, typical of the 8–10% rate reported in the literature (10, 28).